Life Sciences Tools & Services · NYSE

CRLCharles River Laboratories International, Inc.

Last close
$337.97 -0.8%
52-week range
$146.19 to $379.63
Market cap
$16.2B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$4.02B
-1% vs FY24
Net income
-$144M
-750% vs FY24
Free cash flow
$518M
+3% vs FY24
Net cash
-$1.92B
Cash $214M, debt $2.14B

Stock price

+356% since Dec 2016

Valuation vs its own 10 years

Above its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
399x
20.9x1,012x
97th percentile, above its median of 30.7x
Positive-earnings quarters only
Price / sales
4.1x
1.8x6.9x
88th percentile, above its median of 2.7x
EV / EBITDA
41.5x
13.0x41.5x
Highest point in its range, above its median of 16.8x
Price / free cash flow
40.5x
12.8x52.3x
98th percentile, above its median of 22.6x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-26. Every figure carries its unit.

Valuation

P/E
399x
Earnings yield
0.3%
Price / sales
4.1x
Price / book
5.0x
Price / operating cash flow
26.0x
EV / EBITDA
41.5x
EV / sales
4.6x
Free cash flow yield
2.5%

Profitability

Gross margin
n/aNot reported
Operating margin
4.0%
Net margin
1.0%
Return on equity
1.2%
Return on capital
2.2%

Growth per year

Revenue, 3 years
+0.3%
Revenue, 5 years
+6.5%
Revenue, 9 years
+10.2%
EPS, 3 years
n/aNot meaningful (a loss in the window)

Balance sheet

Cash and investments
$200M
Total debt
$2.45B
Net cash
-$2.25B
Debt / equity
0.76x
Current ratio
1.41x

Shares and dividend

Shares outstanding
47.9M
Share count, 5 years
-2.1%
Beta, 1 year
1.27
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $983M
RevenueNet income
Gross profitLatest quarter $349M
EBITDALatest quarter $275M
Margins35 / 21 / 34%
GrossOperatingNet
Earnings per shareLatest quarter $6.86
Cash flowLatest quarter $254M
OperatingCapexFree
Cash vs debtLatest quarter $200M
Cash and investmentsTotal debt
P/E historyNow 399x
P/E, median 30.7x dashed
P/S historyNow 4.1x
P/S, median 2.7x dashed

Where the revenue comes from

Product went from 19% to 19% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

ServicesProduct
FY22
81%19%
$3.98B
FY23
83%17%
$4.13B
FY24
82%18%
$4.05B
FY25
81%19%
$4.02B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Services$3.25B80.9%-2%
Product$765M19.1%+3%

Life Sciences Tools & Services peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
TMO Thermo Fisher Scientific Inc. $259B +8% 17.9%36.9x5.5x 88th percentile
A Agilent Technologies, Inc. $49.0B +9% 22.2%34.2x6.7x 64th percentile
WAT Waters Corp $45.2B +81% 4.7%198x8.1x 90th percentile
IQV Iqvia Holdings Inc. $43.7B +9% 12.8%32.2x2.5x 38th percentile
MTD Mettler Toledo International Inc/ $34.6B +7% n/a37.7x8.2x 58th percentile
CRL Charles River Laboratories International, Inc. $16.2B -1% 4.0%399x4.1x 97th percentile

The company

Sector
Health Care
Industry
Life Sciences Tools & Services
Founded
1947
Headquarters
Wilmington, MA
Fiscal year ends
Late December
Website
criver.com

What it does

Charles River Laboratories International, Incorporated is an American life sciences company and contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides goods and services that support the development of drugs, vaccines, and other therapeutics.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about CRL.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 317 active funds. Crowd level: quiet.

Open the Smart money tab